Suppr超能文献

甲状腺功能亢进症可能独立于心脏功能障碍影响血清N末端B型利钠肽原水平。

Hyperthyroidism may affect serum N-terminal pro-B-type natriuretic peptide levels independently of cardiac dysfunction.

作者信息

Arikan Senay, Tuzcu Alpaslan, Gokalp Deniz, Bahceci Mithat, Danis Ramazan

机构信息

University of Dicle, School of Medicine, Departments of Endocrinology and Nephrology, Diyarbakir, Turkey.

出版信息

Clin Endocrinol (Oxf). 2007 Aug;67(2):202-7. doi: 10.1111/j.1365-2265.2007.02861.x. Epub 2007 Jun 4.

Abstract

BACKGROUND AND AIM

It is known that NT-proBNP levels increase in cardiac failure. However, NT-proBNP levels in different thyroid states are still unclear. We aimed to evaluate serum NT-proBNP levels in both hyperthyroid and hypothyroid patients without cardiac insufficiency.

SUBJECTS AND METHODS

Thirty-six patients with hyperthyroidism (42.9 +/- 16.7 years), 25 patients with hypothyroidism (35.4 +/- 13.9 years) and 34 age-matched euthyroid subjects (41.4 +/- 13.8 years) were included in the study. After anthropometric evaluations, body fat analyses were determined by bioelectrical impedance. Electrocardiography and echocardiography were used in cardiac evaluations. Serum NT-proBNP was measured by immunoassay.

RESULTS

Mean serum NT-proBNP levels in hyperthyroid patients were higher than in both control subjects (13.65 +/- 13.02 vs. 6.50 +/- 4.83 pmol/l, P = 0.002) and hypothyroid patients (13.65 +/- 13.02 vs. 5.98 +/- 5.08 pmol/l, P = 0.003). However, mean serum NT-proBNP levels in hypothyroid patients were not different from those in control subjects. There was a positive correlation between serum NT-proBNP and thyroid hormones (NT-proBNP and FT3: r = 0.324, P = 0.001; NT-proBNP and FT4: r = 0.269, P = 0.009, respectively). Serum NT-proBNP levels were positively correlated with left ventricle end-diastolic diameters (r = 0.232, P = 0.04), interventricular septum thickness (r = 0.315, P = 0.006), and negatively correlated with left ventricular ejection fraction (r = -0.238, P = 0.04).

CONCLUSIONS

Serum NT-proBNP levels may increase in hyperthyroidism independently of cardiac insufficiency. Therefore, hyperthyroidism may lead to cardiac ultrastructural changes undetermined by conventional echocardiography and these changes may be responsible for elevation of NT-proBNP levels. In contrast to decreased thyroid hormones, excess thyroid hormones may have a more pronounced effect on serum NT-proBNP levels.

摘要

背景与目的

已知N末端脑钠肽前体(NT-proBNP)水平在心力衰竭时会升高。然而,不同甲状腺状态下的NT-proBNP水平仍不清楚。我们旨在评估无心脏功能不全的甲状腺功能亢进和甲状腺功能减退患者的血清NT-proBNP水平。

对象与方法

本研究纳入了36例甲状腺功能亢进患者(42.9±16.7岁)、25例甲状腺功能减退患者(35.4±13.9岁)和34例年龄匹配的甲状腺功能正常受试者(41.4±13.8岁)。在进行人体测量评估后,通过生物电阻抗法测定体脂分析。心脏评估采用心电图和超声心动图。血清NT-proBNP通过免疫测定法测量。

结果

甲状腺功能亢进患者的平均血清NT-proBNP水平高于对照组(13.65±13.02对6.50±4.83 pmol/L,P = 0.002)和甲状腺功能减退患者(13.65±13.02对5.98±5.08 pmol/L,P = 0.003)。然而,甲状腺功能减退患者的平均血清NT-proBNP水平与对照组无差异。血清NT-proBNP与甲状腺激素之间存在正相关(NT-proBNP与游离三碘甲状腺原氨酸:r = 0.324,P = 0.001;NT-proBNP与游离甲状腺素:r = 0.269,P = 0.009)。血清NT-proBNP水平与左心室舒张末期直径呈正相关(r = 0.232,P = 0.04)、室间隔厚度呈正相关(r = 0.315,P = 0.006),与左心室射血分数呈负相关(r = -0.238,P = 0.04)。

结论

甲状腺功能亢进时血清NT-proBNP水平可能独立于心脏功能不全而升高。因此,甲状腺功能亢进可能导致常规超声心动图未检测到的心脏超微结构改变,这些改变可能是NT-proBNP水平升高的原因。与甲状腺激素减少相反,甲状腺激素过多可能对血清NT-proBNP水平有更明显的影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验